Overview
Midori Matsushita practices in Japan. Ms. Matsushita is rated as an Advanced expert by MediFind in the treatment of Generalized Resistance to Thyroid Hormone. Her top areas of expertise are Familial Hyperthyroidism due to Mutations in TSH Receptor, Generalized Resistance to Thyroid Hormone, Acute Erythroid Leukemia (AEL), and Chondrosarcoma.
Her clinical research consists of co-authoring 12 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Generalized Resistance to Thyroid Hormone.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Familial Hyperthyroidism due to Mutations in TSH Receptor
- Generalized Resistance to Thyroid HormoneMs. Matsushita isAdvanced. Learn about Generalized Resistance to Thyroid Hormone.
- Experienced
- Acute Erythroid Leukemia (AEL)Ms. Matsushita isExperienced. Learn about Acute Erythroid Leukemia (AEL).
- ChondrosarcomaMs. Matsushita isExperienced. Learn about Chondrosarcoma.